Diabetes, Vol 42, Issue 10 1482-1486, Copyright © 1993 by American Diabetes Association
Diabetic neuropathy 3 years after successful pancreas and kidney transplantation
W Muller-Felber, R Landgraf, R Scheuer, S Wagner, CD Reimers, J Nusser, D Abendroth, WD Illner and W Land
Department of Internal Medicine, University of Munich, Germany.
Twenty-seven patients with successful transplantation and a control group
of 14 patients with early rejection of the pancreas graft but functioning
kidney graft were examined in a prospective study for 3 yr. Before
transplantation, all patients had long-standing type I diabetes with
advanced secondary complications, including end-stage diabetic nephropathy.
After transplantation in the patients of both groups, kidney function was
almost normal. Mean HbA1 levels were normal in the group with pancreas
graft survival. In the control group, HbA1 levels were, on average, 1.5%
higher compared with the group with pancreas survival (P = 0.00005). After
3 yr, the patients with functioning pancreas graft showed fewer symptoms
(mean difference 1.0 in a symptom score ranging from 0 to 16, P = 0.004)
compared with the control group. No statistically significant difference
between both groups concerning clinical signs of polyneuropathy could be
observed. In the pancreas and kidney transplantation group, peroneal and
median nerve conduction velocities increased 7.2 m/s (P < 0.01) and 3.5
m/s (P < 0.05), respectively, whereas no increase was registered in the
control group. The change of median and sural sensory nerve conduction
velocities, peroneal and median compound muscle action potentials, and
sural and median sensory action potentials was insignificant. In
conclusion, although the improvement of clinical symptoms and
neurophysiological signs of polyneuropathy was modest in the pancreas and
kidney transplantation group, our data suggest that successful pancreas
transplantation is able not only to halt the progression of diabetic
polyneuropathy but also to improve it to some extent even at a far advanced
stage.